<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharmaspecific training | Activités du site</title>
	<link>https://pharmaspecific-training.com/activity/</link>
	<atom:link href="https://pharmaspecific-training.com/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Fil d&#039;activité de tout le site</description>
	<lastBuildDate>Tue, 23 Dec 2025 11:48:09 +0100</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>fr-FR</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">2f57c77f2b5ab879ced934541e113708</guid>
				<title>pharmadmin2 a écrit un nouvel article</title>
				<link>https://pharmaspecific-training.com/?p=7292</link>
				<pubDate>Wed, 28 May 2025 07:07:25 +0200</pubDate>

									<content:encoded><![CDATA[<p>Bien plus qu’un simple exécutant, l’ARC moniteur joue un rôle stratégique dans le domaine de la recherche clinique. Sans disposer d’autorité hiérarchique, il sait mobiliser, coordonner et faire converger [&hellip;] <img loading="lazy" src="https://pharmaspecific-training.com/wp-content/uploads/2025/05/image-4.png" /></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">764061fcf848ba0fd50e5a2ed37d9607</guid>
				<title>pharmadmin2 a écrit un nouvel article</title>
				<link>https://pharmaspecific-training.com/?p=7297</link>
				<pubDate>Wed, 28 May 2025 07:02:08 +0200</pubDate>

									<content:encoded><![CDATA[<p>Un stage en recherche clinique, que ce soit en tant qu’attaché de recherche clinique (ARC) ou en technicien d’essai clinique (TEC), est une opportunité précieuse pour débuter dans le domaine. Si ton expérie [&hellip;] <img loading="lazy" src="https://pharmaspecific-training.com/wp-content/uploads/2025/05/image.png" /></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ba4fd6161b73b341c5753dbef62740da</guid>
				<title>pharmadmin2 a écrit un nouvel article</title>
				<link>https://pharmaspecific-training.com/?p=7287</link>
				<pubDate>Fri, 23 May 2025 14:32:03 +0200</pubDate>

									<content:encoded><![CDATA[<p>Challenge #6 My patient’s medical record is lost! What can I do?This year will be a year of meeting, sharing, knowledge and development. Are you ready with us It will start with our 2020 challenge, one video per d [&hellip;]</p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c944818736eb2cf4c948bd46bd4fc06b</guid>
				<title>pharmadmin2 a écrit un nouvel article</title>
				<link>https://pharmaspecific-training.com/?p=7256</link>
				<pubDate>Sat, 21 Sep 2024 02:16:58 +0200</pubDate>

									<content:encoded><![CDATA[<p>Découvrez comment se constituer un réseau solide pour optimiser ta carrière en recherche clinique.IntroductionLe monde de la recherche clinique est en constante évolution, et pour les ARC et TEC, un réseau prof [&hellip;]</p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">3b6aff9c2ace4b98b4905ffb561104f0</guid>
				<title>pharmadmin2 a écrit un nouvel article</title>
				<link>https://pharmaspecific-training.com/?p=7259</link>
				<pubDate>Sat, 21 Sep 2024 01:43:18 +0200</pubDate>

									<content:encoded><![CDATA[<p>Rédigé par l’équipe de Pharmaspecific.IntroductionCes dernières années, la technologie a révolutionné presque tous les aspects de notre vie et la recherche clinique ne fait pas exception. Avec l’avènem [&hellip;] <img loading="lazy" src="https://pharmaspecific-training.com/wp-content/uploads/2024/09/1f449-1f3fd.png" /></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">20d24e324400a9f4dae3aad493b93e49</guid>
				<title>pharmadmin2 a écrit un nouvel article</title>
				<link>https://pharmaspecific-training.com/?p=7262</link>
				<pubDate>Wed, 10 Jul 2024 14:03:06 +0200</pubDate>

									<content:encoded><![CDATA[<p>Article written by the Pharmaspecific Society, a specialist in clinical research.<br />
Hello everyone! This is Vanessa Montanari from the clinical research blog.<br />
Today, I’m making a little video on « You can’t find [&hellip;]</p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">dc28574b9bb8c5ae9953b88470bd74d8</guid>
				<title>Cours ré-initialisé pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17251/</link>
				<pubDate>Mon, 22 Aug 2022 11:29:49 +0200</pubDate>

									<content:encoded><![CDATA[<p>Cours Documents essentiels version 1, 5 October 2018  ré-initialisé pour le participant <a href="https://internal.pharmaspecific-training.com/members/sgharbia/" rel="nofollow ugc">Sara Gharbia</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2aedd4e1bb52a6dd502106cb62aed3d9</guid>
				<title>Le participant a obtenu un Certificat en formation %s</title>
				<link>https://pharmaspecific-training.com/activity/p/17079/</link>
				<pubDate>Tue, 21 Jun 2022 08:57:50 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu un Certificat en formation GCP training for CRA (BPC pour les ARC) version 1, 23 Août 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0f7139684504db0b17ac56dd13f465ad</guid>
				<title>Le formateur a évalué la formation pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17078/</link>
				<pubDate>Tue, 21 Jun 2022 08:57:50 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 100/100 en formation GCP training for CRA (BPC pour les ARC) version 1, 23 Août 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0a3b626a99c3e416c241f46fd550929d</guid>
				<title>﻿Le participant a soumis à la Formation</title>
				<link>https://pharmaspecific-training.com/activity/p/17077/</link>
				<pubDate>Tue, 21 Jun 2022 08:57:50 +0200</pubDate>

									<content:encoded><![CDATA[<p>﻿Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a fini et soumis la formation GCP training for CRA (BPC pour les ARC) version 1, 23 Août 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f41bc09aef2e253bca9230ba6b5512fc</guid>
				<title>Le Questionnaire a été évalué par le formateur pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17076/</link>
				<pubDate>Tue, 21 Jun 2022 08:57:21 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 50 sur 50 dans le quiz CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6e64cd477ee87b82d9a6f7275968dd8a</guid>
				<title>Le participant a soumis au Questiaonaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17075/</link>
				<pubDate>Tue, 21 Jun 2022 08:57:21 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le quiz CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS) a été remis par l&rsquo;étuidiant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">da98f7407463af520a94b6b417704b50</guid>
				<title>Le participant a démarré le questionnaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17074/</link>
				<pubDate>Tue, 21 Jun 2022 08:56:30 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a démarré le questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ef99a9844e903582a05b2e2ee426c1ce</guid>
				<title>Le participant a démarré le questionnaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17073/</link>
				<pubDate>Tue, 21 Jun 2022 08:55:34 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a démarré le questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ff0a83141f5209126f47ca8782acc20e</guid>
				<title>Quiz repris par le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17072/</link>
				<pubDate>Tue, 21 Jun 2022 08:55:27 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant  <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a repris le Questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fa28e4b0bfb1f39e052be4fc15674ce0</guid>
				<title>Quiz repris par le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17071/</link>
				<pubDate>Tue, 21 Jun 2022 08:55:20 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant  <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a repris le Questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5462bfa05ec6d4f4024e15631c54d31d</guid>
				<title>Le Questionnaire a été évalué par le formateur pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17070/</link>
				<pubDate>Tue, 21 Jun 2022 08:54:57 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 5 sur 50 dans le quiz CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">74ec3a2f464f28e1182e780f23cd0d08</guid>
				<title>Le participant a soumis au Questiaonaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17069/</link>
				<pubDate>Tue, 21 Jun 2022 08:54:57 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le quiz CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS) a été remis par l&rsquo;étuidiant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dc40eec5cd4a3765ec17ac83e0399368</guid>
				<title>Le participant a démarré le questionnaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17068/</link>
				<pubDate>Tue, 21 Jun 2022 08:54:18 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a démarré le questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8f6bc34eb8f98c6440f4df896d5ca217</guid>
				<title>Le participant a démarré le questionnaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17067/</link>
				<pubDate>Tue, 21 Jun 2022 08:54:10 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a démarré le questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fa8af6fb09f2e92a2006dd823ce0fda7</guid>
				<title>Le participant a démarré le questionnaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17066/</link>
				<pubDate>Tue, 21 Jun 2022 08:54:08 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a démarré le questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">43d1607b683cf340505e84a439998c2b</guid>
				<title>Quiz repris par le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17065/</link>
				<pubDate>Tue, 21 Jun 2022 08:53:46 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant  <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a repris le Questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4582fcf215c031f46eaf0c4d06194663</guid>
				<title>Quiz repris par le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17064/</link>
				<pubDate>Tue, 21 Jun 2022 08:53:42 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant  <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a repris le Questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1d71e45447a648743aef94db9ca17c5b</guid>
				<title>Quiz repris par le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17063/</link>
				<pubDate>Tue, 21 Jun 2022 08:53:38 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant  <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a repris le Questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fa66ca8ec1c06a1a2918174215141389</guid>
				<title>Le Questionnaire a été évalué par le formateur pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17062/</link>
				<pubDate>Tue, 21 Jun 2022 08:53:24 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 0 sur 50 dans le quiz CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a49461519aebf0f647d3047c3e112ab9</guid>
				<title>Le participant a soumis au Questiaonaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17061/</link>
				<pubDate>Tue, 21 Jun 2022 08:53:24 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le quiz CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS) a été remis par l&rsquo;étuidiant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0f3a8b8df9cc94ed0903fa37c50ac69a</guid>
				<title>Le participant a démarré le questionnaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17060/</link>
				<pubDate>Tue, 21 Jun 2022 08:52:09 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a démarré le questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d16f406361f89e52cf7ef92e287e14f7</guid>
				<title>Quiz repris par le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17059/</link>
				<pubDate>Tue, 21 Jun 2022 08:51:56 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant  <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a repris le Questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">84bacc0fce09db22a9412d63fda80e8b</guid>
				<title>Le Questionnaire a été évalué par le formateur pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17058/</link>
				<pubDate>Tue, 21 Jun 2022 08:51:46 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 0 sur 50 dans le quiz CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">22a5995a7503e13ef09ea79f48b89bdb</guid>
				<title>Le participant a soumis au Questiaonaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17057/</link>
				<pubDate>Tue, 21 Jun 2022 08:51:46 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le quiz CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS) a été remis par l&rsquo;étuidiant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e206d1a279e05c734d2cf11b3ba42216</guid>
				<title>Le participant a démarré le questionnaire</title>
				<link>https://pharmaspecific-training.com/activity/p/17056/</link>
				<pubDate>Tue, 21 Jun 2022 08:51:11 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a démarré le questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1cda8701902f0f8a2ddf2d2025f0edcd</guid>
				<title>Quiz repris par le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17055/</link>
				<pubDate>Tue, 21 Jun 2022 08:50:58 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant  <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a repris le Questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7ea3d83c120cd6f10fbbabdfa15d3fde</guid>
				<title>Quiz repris par le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17054/</link>
				<pubDate>Tue, 21 Jun 2022 08:50:55 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant  <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a repris le Questionnaire CONTRÔLE DES CONNAISSANCES – BPC DE L’ICH POUR LES ARC (10 QUESTIONS)</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9c1fd614687a8e082cdfdc96be187286</guid>
				<title>Le participant a obtenu un Certificat en formation %s</title>
				<link>https://pharmaspecific-training.com/activity/p/17053/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:17 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu un Certificat en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">edb37b62328a58b70ff67441044b8444</guid>
				<title>Le formateur a évalué la formation pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17052/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:17 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 100/100 en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7c601e9e60e681c5bca0986c2f0fbe4f</guid>
				<title>﻿Le participant a soumis à la Formation</title>
				<link>https://pharmaspecific-training.com/activity/p/17051/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:17 +0200</pubDate>

									<content:encoded><![CDATA[<p>﻿Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a fini et soumis la formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dcd24e818a6904a6248d6ae30127a29b</guid>
				<title>Le participant a obtenu un Certificat en formation %s</title>
				<link>https://pharmaspecific-training.com/activity/p/17050/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:15 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu un Certificat en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ba794f75c0e89f60a9cf53c30030bbc8</guid>
				<title>Le formateur a évalué la formation pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17049/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:15 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 100/100 en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">518cfa8bff06507d6b76ee31780f5ee7</guid>
				<title>﻿Le participant a soumis à la Formation</title>
				<link>https://pharmaspecific-training.com/activity/p/17048/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:15 +0200</pubDate>

									<content:encoded><![CDATA[<p>﻿Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a fini et soumis la formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3a451a35fd679da54f58f18f039a4d6d</guid>
				<title>Le participant a obtenu un Certificat en formation %s</title>
				<link>https://pharmaspecific-training.com/activity/p/17047/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:13 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu un Certificat en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">12ec957e9a70cdbe0371ecaa6ec09bde</guid>
				<title>Le formateur a évalué la formation pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17046/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:13 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 100/100 en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">670f46fe0374a7a03a27a4091ddbc51a</guid>
				<title>﻿Le participant a soumis à la Formation</title>
				<link>https://pharmaspecific-training.com/activity/p/17045/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:13 +0200</pubDate>

									<content:encoded><![CDATA[<p>﻿Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a fini et soumis la formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e0c5af3225f35346eade28847d345738</guid>
				<title>Le participant a obtenu un Certificat en formation %s</title>
				<link>https://pharmaspecific-training.com/activity/p/17044/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:11 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu un Certificat en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7d6eb975de76f3a31f29b04194438326</guid>
				<title>Le formateur a évalué la formation pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17043/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:11 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 100/100 en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">aa415fbe445222ab1d613c0bc4f378ed</guid>
				<title>﻿Le participant a soumis à la Formation</title>
				<link>https://pharmaspecific-training.com/activity/p/17042/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:11 +0200</pubDate>

									<content:encoded><![CDATA[<p>﻿Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a fini et soumis la formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4bb2d8b070209b59484b7c581914cbbd</guid>
				<title>Le participant a obtenu un Certificat en formation %s</title>
				<link>https://pharmaspecific-training.com/activity/p/17041/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:09 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu un Certificat en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">be6eab8f9e48ba663c6e97a4403044f3</guid>
				<title>Le formateur a évalué la formation pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17040/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:09 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 100/100 en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e95d6a0c6ccd3ca5fec76deb1b22b044</guid>
				<title>﻿Le participant a soumis à la Formation</title>
				<link>https://pharmaspecific-training.com/activity/p/17039/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:09 +0200</pubDate>

									<content:encoded><![CDATA[<p>﻿Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a fini et soumis la formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">50a2a9986c8da6a02675b0ad1a8d4a05</guid>
				<title>Le participant a obtenu un Certificat en formation %s</title>
				<link>https://pharmaspecific-training.com/activity/p/17038/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:04 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu un Certificat en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">efda8db64eb2af52f54948f0b13a890c</guid>
				<title>Le formateur a évalué la formation pour le participant</title>
				<link>https://pharmaspecific-training.com/activity/p/17037/</link>
				<pubDate>Tue, 21 Jun 2022 08:48:04 +0200</pubDate>

									<content:encoded><![CDATA[<p>Le participant <a href="https://internal.pharmaspecific-training.com/members/ibtissam/" rel="nofollow ugc">Ibtissam Hamimed</a> a obtenu 100/100 en formation GCP training for investigators and site clinical coordinators version 1, 5 October 2018</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>